Butyroyl-arginine as a potent virus inactivation agent

International Journal of Pharmaceutics

Volumn 361, Issue 1-2, 2008, Pages 92-98

  Katsuyama, Yukiko ^a   Yamasaki, Hisashi ^a   Tsujimoto, Kazuko ^a   Koyama, A Hajime ^a   Ejima, Daisuke ^b   Arakawa, Tsutomu ^c  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c ALLIANCE PROTEIN LABORATORIES   (United States)

Author keywords

Arginine; Butyroyl arginine; Influenza virus; Sendai virus; Virus inactivation

Indexed keywords

ARGININE; ARGININE DERIVATIVE; BUTYROYLARGININE; CITRIC ACID; RECOMBINANT ANTIBODY; RECOMBINANT PROTEIN; VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

ACIDITY; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; DRUG MANUFACTURE; DRUG POTENCY; HERPES SIMPLEX VIRUS 1; INFLUENZA VIRUS; LOW TEMPERATURE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SENDAI VIRUS; VIRUS INACTIVATION;

ANIMALS; ANTIVIRAL AGENTS; ARGININE; CELL LINE; CERCOPITHECUS AETHIOPS; DOGS; HYDROGEN-ION CONCENTRATION; KIDNEY; NEWCASTLE DISEASE VIRUS; SENDAI VIRUS; TEMPERATURE; VERO CELLS; VIRUS INACTIVATION;

EID: 47949084283     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.05.020     Document Type: Article

References (37)

1. Arakawa T., Ejima D., et al. Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects. Biophys. Chem. 127 (2007) 1-8
2. Arakawa T., Kita Y., et al. Aggregation suppression of protein by arginine. Protein Pept. Lett. 13 (2006) 921-927
3. Arakawa T., Philo J.S., et al. Elution of antibodies from a Protein-A column by aqueous arginine solutions. Protein Expr. Purif. 36 (2004) 244-248
4. Arakawa T., and Tsumoto K. The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem. Biophys. Res. Commun. 304 (2003) 148-152
5. Brorson K., Krejci S., et al. Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. Biotechnol. Bioeng. 82 (2003) 321-329
6. Brorson K., and Norling L. Current and future approaches to ensure the viral safety of biopharmaceuticals. Dev. Biol. 118 (2004) 17-29
7. Buchacher A., and Iberer G. Purification of intravenous immunoglobulin G from human plasma-aspects of yield and virus safety. Biotechnol. J. 1 (2006) 148-163
8. Ejima D., Tsumoto K., et al. Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies. Proteins 66 (2007) 954-962
9. Ejima D., Yumioka R., et al. Effective elution of antibodies by arginine and arginine derivatives in affinity column chromatography. Anal. Biochem. 345 (2005) 250-257
10. Farshid M., Taffs R.E., et al. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals. Curr. Opin. Biotechnol. 16 (2005) 561-567
11. Futaki S. Membrane-permeable arginine-rich peptides and the translocation mechanism. Adv. Drug Deliv. Rev. 57 (2005) 547-558
12. Ho J.G., Middelberg A.P., et al. The likelihood of aggregation during protein renaturation can be assesses using the second virial coefficient. Protein Sci. 12 (2003) 708-716
13. Ishibashi M., Tsumoto K., et al. Is arginine a protein-denaturant?. Protein Expr. Purif. 42 (2005) 1-6
14. Kaushik J.K., and Bhat R. A mechanistic analysis of the increase in the thermal stability of proteins in aqueous carboxylic acid salt solutions. Protein Sci. 8 (1999) 222-233
15. Kita Y., Arakawa T., et al. Contribution of the surface free energy perturbation to protein-solvent interactions. Biochemistry 33 (1994) 15178-15189
16. Koyama A.H., Irie H., et al. Suppression of apoptotic and necrotic cell death by poliovirus. J. Gen. Virol. 8 (2001) 2965-2972
17. Koyama A.H., Irie H., et al. Virus multiplication and induction of apoptosis by Sendai virus: role of C proteins. Microbes Infection 5 (2003) 373-378
18. Koyama A.H., and Uchida T. The mode of entry of herpes simplex virus type 1 into Vero cells. Microbiol. Immunol. 31 (1987) 123-130
19. Koyama A.H., and Uchida T. The effect of ammonium chloride on the multiplication of herpes simplex virus type 1 in Vero cells. Virus Res. 13 (1989) 271-282
20. Kurokawa M., Koyama A.H., et al. Influenza virus overcomes apoptosis by rapid multiplication. Int. J. Mol. Med. 3 (1999) 527-530
21. Lin T.Y., and Timasheff S.N. On the role of surface tension in the stabilization of globular proteins. Protein Sci. 5 (1996) 372-381
22. Martsef S.P., Kravchuk Z.I., et al. Large increase in thermal stability of the CH2 domain of rabbit IgG after acid treatment as evidenced by differential scanning calorimetry. Immunol. Lett. 43 (1994) 149-152
23. Martsef S.P., Kravxhuk Z.I., et al. Thermodynamic and functional characterization of a stable IgG conformer obtained by renaturation from a partially structured low pH-induced state. FEBS Lett. 361 (1995) 173-175
24. Preuss T., Kamstrup S., et al. Comparison of two different methods for inactivation of viruses in serum. Clin. Diagn. Lab. Immunol. 4 (1997) 504-508
25. Reddy K.R.C., Lilie H., et al. l-Arginine increases the solbility of unfolded species of hen egg lysozyme. Protein Sci. 14 (2005) 929-935
26. Roberts P.L., and Lloyd D. Virus inactivation by protein denaturants used in affinity chromatography. Biologicals 35 (2007) 343-347
27. Shi L., Chen Q., et al. Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification. Biotechnol. Bioeng. 87 (2004) 884-896
28. Shiraki K., Kudou M., et al. Biophysical effect of amino acids on the prevention of protein aggregation. J. Biochem. (Tokyo) 132 (2002) 591-595
29. Tsumoto K., Ejima D., et al. Review: why is arginine effective in suppressing aggregation?. Protein Pept. Lett. 12 (2005) 613-619
30. Tsumoto K., Ejima D., et al. Arginine improves protein elution in hydrophobic interaction chromatography. The cases of human interleukin-6 and activin-A. J. Chromatogr. A. 1154 (2007) 81-86
31. Tsumoto K., Umetsu M., et al. Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine. Biochem. Biophys. Res. Commun. 312 (2003) 1383-1386
32. Tsumoto K., Umetsu M., et al. Role of arginine in protein refolding, solubilization, and purification. Biotechnol. Prog. 20 (2004) 1301-1308
33. Umetsu M., Tsumoto K., Nitta S., et al. Nondenaturing solubilization of beta2 microglobulin from inclusion bodies by L-arginine. Biochem. Biophys. Res. Commun. 328 (2005) 189-197
34. Uozaki M., Yamasaki H., et al. Antiviral effect of octyl gallate against DNA and RNA viruses. Antiviral Res. 73 (2007) 85-91
35. Vermeer A.W.P., and Norde W. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys. J. 78 (2000) 394-404
36. Yamasaki H., Tsujimoto K., et al. Arginine facilitates inactivation of enveloped viruses. J Pharm Sci 97 (2008) 3067-3073
37. Yamasaki H., Uozaki M., et al. Antiviral effect of octyl gallate against influenza and other RNA viruses. Int. J. Mol. Med. 19 (2007) 685-688